DNMT1 and acute myeloid leukemia: Interestingly, we observed a significant reduction in DNMT1 levels following BZM treatment in MCL cells (Supplementary Figure 1B) similar to the results on AML cells reporting BZM as a potent inhibitor of DNA methylation [6].